ONTOLOGY REPORT - ANNOTATIONS
| Term: | 2,2',4,4',5,5'-hexachlorobiphenyl |
|
| Accession: | CHEBI:34202
|
browse the term
|
| Definition: | A hexachlorobiphenyl that has formula C12H4Cl6. |
| Synonyms: | related_synonym: | 1,1'-Biphenyl, 2,2',4,4',5,5'-hexachloro-; C12H4Cl6; Clc1cc(Cl)c(cc1Cl)-c1cc(Cl)c(Cl)cc1Cl; InChI=1S/C12H4Cl6/c13-7-3-11(17)9(15)1-5(7)6-2-10(16)12(18)4-8(6)14/h1-4H; InChIKey=MVWHGTYKUMDIHL-UHFFFAOYSA-N |
| | xref_casrn: | 35065-27-1 |
| | xref: | Beilstein:1990497 "Beilstein Registry Number"; ChEMBL:113795 "ChEMBL COMPOUND"; ChemIDplus:35065-27-1 "CAS Registry Number"; KEGG COMPOUND:35065-27-1 "CAS Registry Number"; KEGG COMPOUND:C14201 "KEGG COMPOUND" |
| | xref_mesh: | MESH:C014024 |
| | xref: | NIST Chemistry WebBook:35065-27-1 "CAS Registry Number" |
|
|
2,2',4,4',5,5'-hexachlorobiphenyl
|
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
EXP |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abhd2 |
abhydrolase domain containing 2 |
|
decreases expression |
ISO |
1 |
135,025,144 |
135,111,792 |
RGD:6480464 |
CTD |
| G |
Ablim3 |
actin binding LIM protein family, member 3 |
|
affects expression |
ISO |
18 |
57,781,588 |
57,900,968 |
RGD:6480464 |
CTD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
decreases expression |
ISO |
9 |
78,083,239 |
78,106,933 |
RGD:6480464 |
CTD |
| G |
Acsm2a |
acyl-CoA synthetase medium-chain family member 2A |
|
multiple interactions |
EXP |
1 |
177,830,613 |
177,869,061 |
RGD:6480464 |
CTD |
| G |
Actl7b |
actin-like 7b |
|
decreases expression |
ISO |
5 |
74,646,523 |
74,647,911 |
RGD:6480464 |
CTD |
| G |
Adamtsl2 |
ADAMTS-like 2 |
|
increases expression |
ISO |
3 |
5,976,490 |
6,004,532 |
RGD:6480464 |
CTD |
| G |
Adamtsl5 |
ADAMTS-like 5 |
|
decreases expression |
ISO |
7 |
10,874,586 |
10,879,783 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
decreases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Agpat4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
|
decreases expression |
ISO |
1 |
42,986,809 |
43,096,390 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects localization |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects activity |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
affects expression |
ISO |
1 |
34,979,039 |
35,068,763 |
RGD:6480464 |
CTD |
| G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
|
increases expression |
ISO |
4 |
61,794,352 |
61,806,916 |
RGD:6480464 |
CTD |
| G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
|
multiple interactions |
ISO |
4 |
61,794,352 |
61,806,916 |
RGD:6480464 |
CTD |
| G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
|
increases expression |
ISO |
4 |
61,794,352 |
61,806,916 |
RGD:6480464 |
CTD |
| G |
Akr1c19 |
aldo-keto reductase family 1, member C19 |
|
increases expression |
ISO |
17 |
77,162,221 |
77,183,258 |
RGD:6480464 |
CTD |
| G |
Akt3 |
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) |
|
affects expression |
ISO |
13 |
92,802,390 |
93,110,704 |
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alas1 |
aminolevulinate, delta-, synthase 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Alcam |
activated leukocyte cell adhesion molecule |
|
multiple interactions |
EXP |
11 |
49,424,243 |
49,630,071 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh3b2 |
aldehyde dehydrogenase 3 family, member B2 |
|
affects expression |
ISO |
1 |
206,549,529 |
206,553,424 |
RGD:6480464 |
CTD |
| G |
Aoc2-ps1 |
amine oxidase, copper containing 2 (retina-specific), pseudogene 1 |
|
decreases expression |
ISO |
10 |
90,352,884 |
90,354,299 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
increases expression |
ISO |
9 |
56,693,698 |
56,774,115 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
multiple interactions |
ISO |
9 |
56,693,698 |
56,774,115 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
increases expression |
ISO |
9 |
56,693,698 |
56,774,115 |
RGD:6480464 |
CTD |
| G |
Ap3b2 |
adaptor-related protein complex 3, beta 2 subunit |
|
affects expression |
ISO |
1 |
137,672,485 |
137,675,472 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Asgr2 |
asialoglycoprotein receptor 2 |
|
decreases expression |
ISO |
10 |
56,942,683 |
56,955,742 |
RGD:6480464 |
CTD |
| G |
Atg14 |
autophagy related 14 |
|
decreases expression |
ISO |
15 |
23,511,665 |
23,543,023 |
RGD:6480464 |
CTD |
| G |
Atoh1 |
atonal homolog 1 (Drosophila) |
|
increases expression |
EXP |
4 |
94,109,650 |
94,111,745 |
RGD:6480464 |
CTD |
| G |
Atp6v1c2 |
ATPase, H+ transporting, lysosomal V1 subunit C2 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Axin2 |
axin 2 |
|
decreases expression |
EXP |
10 |
98,294,466 |
98,321,830 |
RGD:6480464 |
CTD |
| G |
Axin2 |
axin 2 |
|
multiple interactions |
EXP |
10 |
98,294,466 |
98,321,830 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
affects expression |
ISO |
19 |
41,646,190 |
41,669,234 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
multiple interactions |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bmp1 |
bone morphogenetic protein 1 |
|
affects expression |
ISO |
15 |
50,878,144 |
50,922,313 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
multiple interactions |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
C1qtnf5 |
C1q and tumor necrosis factor related protein 5 |
|
decreases expression |
ISO |
8 |
47,089,564 |
47,091,434 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
multiple interactions |
EXP |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Cadps |
Ca++-dependent secretion activator |
|
multiple interactions |
EXP |
15 |
13,859,286 |
14,319,814 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
affects expression |
ISO |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
multiple interactions |
ISO |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
multiple interactions |
EXP |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
increases expression |
ISO |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
increases expression |
EXP |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
affects expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Ccdc65 |
coiled-coil domain containing 65 |
|
decreases expression |
ISO |
7 |
137,474,981 |
137,489,918 |
RGD:6480464 |
CTD |
| G |
Cck |
cholecystokinin |
|
multiple interactions |
EXP |
8 |
126,492,636 |
126,499,220 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
ISO |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
affects expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
affects expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
affects expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
affects expression |
ISO |
5 |
36,465,490 |
36,483,538 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases degradation |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases phosphorylation |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
decreases expression |
ISO |
8 |
128,907,157 |
128,912,272 |
RGD:6480464 |
CTD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
multiple interactions |
ISO |
8 |
128,907,157 |
128,912,272 |
RGD:6480464 |
CTD |
| G |
Cd1d1 |
CD1d1 molecule |
|
decreases expression |
ISO |
2 |
179,011,165 |
179,014,672 |
RGD:6480464 |
CTD |
| G |
Cdc25a |
cell division cycle 25A |
|
affects expression |
ISO |
8 |
114,237,704 |
114,255,971 |
RGD:6480464 |
CTD |
| G |
Cdca2 |
cell division cycle associated 2 |
|
increases expression |
ISO |
15 |
47,225,711 |
47,271,412 |
RGD:6480464 |
CTD |
| G |
Cdcp1 |
CUB domain containing protein 1 |
|
increases expression |
ISO |
8 |
127,951,811 |
127,988,666 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
EXP |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases degradation |
EXP |
19 |
36,442,693 |
36,512,091 |
RGD:6480464 |
CTD |
| G |
Cds2 |
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 |
|
increases expression |
ISO |
3 |
120,025,455 |
120,063,992 |
RGD:6480464 |
CTD |
| G |
Cel |
carboxyl ester lipase |
|
decreases expression |
ISO |
3 |
7,541,127 |
7,549,245 |
RGD:6480464 |
CTD |
| G |
Ces1d |
carboxylesterase 1D |
|
multiple interactions |
EXP |
19 |
14,928,539 |
14,967,082 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
increases expression |
ISO |
19 |
34,910,981 |
34,925,547 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
increases expression |
EXP |
19 |
34,910,981 |
34,925,547 |
RGD:6480464 |
CTD |
| G |
Ces3a |
carboxylesterase 3a |
|
multiple interactions |
EXP |
19 |
34,929,247 |
34,937,267 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
increases expression |
EXP |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
increases expression |
EXP |
18 |
63,871,538 |
63,896,975 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions |
EXP |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Cldn10 |
claudin 10 |
|
increases expression |
EXP |
15 |
103,699,243 |
103,793,405 |
RGD:6480464 |
CTD |
| G |
Cldn5 |
claudin 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Clec10a |
C-type lectin domain family 10, member A |
|
decreases expression |
ISO |
10 |
56,998,778 |
57,002,953 |
RGD:6480464 |
CTD |
| G |
Clec7a |
C-type lectin domain family 7, member A |
|
multiple interactions |
ISO |
4 |
166,723,515 |
166,734,681 |
RGD:6480464 |
CTD |
| G |
Cpa1 |
carboxypeptidase A1 (pancreatic) |
|
multiple interactions |
EXP |
4 |
57,549,260 |
57,555,361 |
RGD:6480464 |
CTD |
| G |
Csrp2 |
cysteine and glycine-rich protein 2 |
|
increases expression |
EXP |
7 |
49,910,235 |
49,929,536 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases degradation |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases expression |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl13 |
chemokine (C-X-C motif) ligand 13 |
|
multiple interactions |
EXP |
14 |
15,126,332 |
15,131,368 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
increases expression |
ISO |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Cybb |
cytochrome b-245, beta polypeptide |
|
multiple interactions |
ISO |
X |
25,514,572 |
25,547,181 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
increases expression |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
increases expression |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
affects expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases response to substance |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases activity |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
affects expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases activity |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases response to substance |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
|
increases expression |
ISO |
1 |
81,408,436 |
81,582,029 |
RGD:6480464 |
CTD |
| G |
Cyp2b15 |
cytochrome P450, family 2, subfamily b, polypeptide 15 |
|
increases expression |
EXP |
1 |
81,839,930 |
81,852,366 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
ISO |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b21 |
cytochrome P450, family 2, subfamily b, polypeptide 21 |
|
increases expression |
ISO |
1 |
81,658,154 |
81,687,123 |
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases expression |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
increases expression |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c80 |
cytochrome P450, family 2, subfamily c, polypeptide 80 |
|
increases expression |
ISO |
1 |
244,517,262 |
244,536,426 |
RGD:6480464 |
CTD |
| G |
Cyp2j3 |
cytochrome P450, family 2, subfamily j, polypeptide 3 |
|
multiple interactions |
EXP |
5 |
116,744,337 |
116,766,822 |
RGD:6480464 |
CTD |
| G |
Cyp39a1 |
cytochrome P450, family 39, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
12,926,125 |
13,002,576 |
RGD:6480464 |
CTD |
| G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
|
increases expression |
ISO |
12 |
9,086,752 |
9,136,606 |
RGD:6480464 |
CTD |
| G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
|
increases expression |
ISO |
12 |
9,086,752 |
9,136,606 |
RGD:6480464 |
CTD |
| G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
|
increases expression |
EXP |
12 |
9,086,752 |
9,136,606 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
multiple interactions |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
increases expression |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
multiple interactions |
EXP |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
multiple interactions |
EXP |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
multiple interactions |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Depdc7 |
DEP domain containing 7 |
|
decreases expression |
ISO |
3 |
90,054,620 |
90,075,902 |
RGD:6480464 |
CTD |
| G |
Dexi |
dexamethasone-induced transcript |
|
decreases expression |
ISO |
10 |
5,072,036 |
5,084,723 |
RGD:6480464 |
CTD |
| G |
Dexi |
dexamethasone-induced transcript |
|
multiple interactions |
ISO |
10 |
5,072,036 |
5,084,723 |
RGD:6480464 |
CTD |
| G |
Dhfr |
dihydrofolate reductase |
|
decreases expression |
ISO |
2 |
22,607,093 |
22,828,487 |
RGD:6480464 |
CTD |
| G |
Dhx40 |
DEAH (Asp-Glu-Ala-His) box polypeptide 40 |
|
decreases expression |
ISO |
10 |
75,043,705 |
75,080,633 |
RGD:6480464 |
CTD |
| G |
Dock7 |
dedicator of cytokinesis 7 |
|
decreases expression |
ISO |
5 |
119,377,149 |
119,535,973 |
RGD:6480464 |
CTD |
| G |
Dtymk |
deoxythymidylate kinase (thymidylate kinase) |
|
affects expression |
ISO |
9 |
93,065,333 |
93,074,168 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
multiple interactions |
EXP |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dusp9 |
dual specificity phosphatase 9 |
|
decreases expression |
ISO |
X |
159,538,012 |
159,541,937 |
RGD:6480464 |
CTD |
| G |
Dysf |
dysferlin |
|
multiple interactions |
ISO |
4 |
118,213,435 |
118,371,283 |
RGD:6480464 |
CTD |
| G |
Dysf |
dysferlin |
|
increases expression |
ISO |
4 |
118,213,435 |
118,371,283 |
RGD:6480464 |
CTD |
| G |
E2f7 |
E2F transcription factor 7 |
|
affects expression |
ISO |
7 |
49,689,755 |
49,751,823 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
affects localization |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
multiple interactions |
ISO |
2 |
226,946,573 |
227,054,321 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
decreases expression |
ISO |
2 |
226,946,573 |
227,054,321 |
RGD:6480464 |
CTD |
| G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
decreases expression |
ISO |
2 |
226,946,573 |
227,054,321 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
increases expression |
EXP |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases activity |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
decreases expression |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Fabp12 |
fatty acid binding protein 12 |
|
multiple interactions |
ISO |
2 |
93,494,781 |
93,510,205 |
RGD:6480464 |
CTD |
| G |
Fabp12 |
fatty acid binding protein 12 |
|
decreases expression |
ISO |
2 |
93,494,781 |
93,510,205 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
decreases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fasn |
fatty acid synthase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fbxl2 |
F-box and leucine-rich repeat protein 2 |
|
affects expression |
ISO |
8 |
118,621,502 |
118,669,052 |
RGD:6480464 |
CTD |
| G |
Fbxo24 |
F-box protein 24 |
|
decreases expression |
ISO |
12 |
19,679,945 |
19,690,296 |
RGD:6480464 |
CTD |
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
multiple interactions |
ISO |
2 |
191,095,026 |
191,103,942 |
RGD:6480464 |
CTD |
| G |
Fcgr2b |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
|
decreases expression |
ISO |
13 |
86,809,011 |
86,823,599 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
multiple interactions |
EXP |
8 |
55,291,396 |
55,310,507 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
multiple interactions |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo5 |
flavin containing monooxygenase 5 |
|
increases expression |
ISO |
2 |
192,463,087 |
192,489,803 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
affects expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxo3 |
forkhead box O3 |
|
decreases phosphorylation |
ISO |
20 |
46,171,784 |
46,262,818 |
RGD:6480464 |
CTD |
| G |
Foxo3 |
forkhead box O3 |
|
multiple interactions |
ISO |
20 |
46,171,784 |
46,262,818 |
RGD:6480464 |
CTD |
| G |
Fzd9 |
frizzled family receptor 9 |
|
decreases expression |
ISO |
12 |
22,581,510 |
22,583,824 |
RGD:6480464 |
CTD |
| G |
Gab1 |
GRB2-associated binding protein 1 |
|
affects expression |
ISO |
19 |
28,980,284 |
29,088,877 |
RGD:6480464 |
CTD |
| G |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor 2 |
|
multiple interactions |
EXP |
5 |
63,241,397 |
63,611,907 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
multiple interactions |
ISO |
10 |
27,258,813 |
27,313,725 |
RGD:6480464 |
CTD |
| G |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
|
multiple interactions |
ISO |
10 |
27,602,085 |
27,819,145 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
multiple interactions |
ISO |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
multiple interactions |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
multiple interactions |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
increases expression |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
increases expression |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Ggta1 |
glycoprotein, alpha-galactosyltransferase 1 |
|
decreases expression |
ISO |
3 |
14,485,028 |
14,559,484 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
EXP |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
affects localization |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gjc1 |
gap junction protein, gamma 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gls2 |
glutaminase 2 (liver, mitochondrial) |
|
multiple interactions |
EXP |
7 |
1,484,397 |
1,495,283 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
multiple interactions |
ISO |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
affects expression |
ISO |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
multiple interactions |
ISO |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
decreases expression |
EXP |
19 |
9,629,687 |
9,655,336 |
RGD:6480464 |
CTD |
| G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2, mitochondrial |
|
increases expression |
ISO |
3 |
38,980,634 |
39,114,492 |
RGD:6480464 |
CTD |
| G |
Gpd2 |
glycerol-3-phosphate dehydrogenase 2, mitochondrial |
|
multiple interactions |
ISO |
3 |
38,980,634 |
39,114,492 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
multiple interactions |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Grm3 |
glutamate receptor, metabotropic 3 |
|
affects expression |
ISO |
4 |
20,745,424 |
22,118,097 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
multiple interactions |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm4 |
glutathione S-transferase mu 4 |
|
increases expression |
ISO |
2 |
203,605,593 |
203,610,817 |
RGD:6480464 |
CTD |
| G |
Gstm4 |
glutathione S-transferase mu 4 |
|
increases expression |
ISO |
2 |
203,605,593 |
203,610,817 |
RGD:6480464 |
CTD |
| G |
Gstm4 |
glutathione S-transferase mu 4 |
|
multiple interactions |
ISO |
2 |
203,605,593 |
203,610,817 |
RGD:6480464 |
CTD |
| G |
Gstt2 |
glutathione S-transferase, theta 2 |
|
increases expression |
ISO |
20 |
13,221,696 |
13,225,367 |
RGD:6480464 |
CTD |
| G |
Gstt3 |
glutathione S-transferase, theta 3 |
|
increases expression |
ISO |
20 |
13,595,934 |
13,603,087 |
RGD:6480464 |
CTD |
| G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
multiple interactions |
EXP |
16 |
7,073,038 |
7,108,830 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
multiple interactions |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hbg1 |
hemoglobin, gamma A |
|
decreases expression |
ISO |
1 |
161,640,359 |
161,641,737 |
RGD:6480464 |
CTD |
| G |
Hes5 |
hairy and enhancer of split 5 (Drosophila) |
|
decreases expression |
EXP |
5 |
171,763,869 |
171,764,636 |
RGD:6480464 |
CTD |
| G |
Hist1h1b |
histone cluster 1, H1b |
|
decreases expression |
ISO |
17 |
50,360,616 |
50,361,284 |
RGD:6480464 |
CTD |
| G |
Hist2h2ab |
histone cluster 2, H2ab |
|
decreases expression |
ISO |
2 |
191,022,967 |
191,023,359 |
RGD:6480464 |
CTD |
| G |
Hk2 |
hexokinase 2 |
|
increases expression |
ISO |
4 |
116,925,725 |
116,975,211 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
decreases expression |
ISO |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
decreases expression |
EXP |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hoxb9 |
homeo box B9 |
|
decreases expression |
ISO |
10 |
85,002,254 |
85,005,760 |
RGD:6480464 |
CTD |
| G |
Hpd |
4-hydroxyphenylpyruvate dioxygenase |
|
multiple interactions |
EXP |
12 |
34,548,320 |
34,558,371 |
RGD:6480464 |
CTD |
| G |
Hrh1 |
histamine receptor H 1 |
|
increases expression |
ISO |
4 |
150,431,239 |
150,432,699 |
RGD:6480464 |
CTD |
| G |
Hs6st1 |
heparan sulfate 6-O-sulfotransferase 1 |
|
affects expression |
ISO |
9 |
34,978,441 |
35,018,289 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
decreases expression |
ISO |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
decreases expression |
ISO |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
affects expression |
ISO |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
|
multiple interactions |
ISO |
1 |
99,563,187 |
99,577,802 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
multiple interactions |
EXP |
1 |
135,876,052 |
135,895,373 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
increases expression |
ISO |
1 |
238,609,171 |
238,611,236 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
decreases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
affects expression |
ISO |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
decreases expression |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
affects expression |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Il10 |
interleukin 10 |
|
decreases expression |
ISO |
13 |
43,953,900 |
43,957,766 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
increases expression |
ISO |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
increases expression |
ISO |
3 |
2,607,800 |
2,613,216 |
RGD:6480464 |
CTD |
| G |
Il33 |
interleukin 33 |
|
multiple interactions |
EXP |
1 |
233,670,801 |
233,685,798 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
increases expression |
ISO |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
increases expression |
ISO |
13 |
33,331,951 |
33,345,132 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
multiple interactions |
ISO |
13 |
33,331,951 |
33,345,132 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
increases expression |
ISO |
13 |
33,331,951 |
33,345,132 |
RGD:6480464 |
CTD |
| G |
Irf8 |
interferon regulatory factor 8 |
|
multiple interactions |
ISO |
19 |
51,100,088 |
51,116,730 |
RGD:6480464 |
CTD |
| G |
Itga7 |
integrin, alpha 7 |
|
multiple interactions |
EXP |
7 |
2,230,747 |
2,269,403 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
affects expression |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Itgb8 |
integrin, beta 8 |
|
affects expression |
ISO |
6 |
146,494,978 |
146,573,064 |
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
increases phosphorylation |
ISO |
5 |
121,804,586 |
121,905,581 |
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
multiple interactions |
ISO |
5 |
121,804,586 |
121,905,581 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
affects expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jup |
junction plakoglobin |
|
increases degradation |
EXP |
10 |
89,307,938 |
89,335,254 |
RGD:6480464 |
CTD |
| G |
Kiss1 |
KiSS-1 metastasis-suppressor |
|
multiple interactions |
EXP |
13 |
46,244,786 |
46,247,288 |
RGD:6480464 |
CTD |
| G |
Kiss1r |
KISS1 receptor |
|
multiple interactions |
EXP |
7 |
11,297,840 |
11,301,187 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
affects expression |
ISO |
7 |
73,821,190 |
73,826,866 |
RGD:6480464 |
CTD |
| G |
Klrg1 |
killer cell lectin-like receptor subfamily G, member 1 |
|
decreases expression |
EXP |
4 |
158,673,698 |
158,684,674 |
RGD:6480464 |
CTD |
| G |
L3hypdh |
L-3-hydroxyproline dehydratase (trans-) |
|
multiple interactions |
EXP |
6 |
94,270,120 |
94,280,916 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
decreases expression |
EXP |
2 |
56,426,058 |
56,477,198 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
EXP |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lrit1 |
leucine-rich repeat, immunoglobulin-like and transmembrane domains 1 |
|
decreases expression |
ISO |
16 |
13,262,817 |
13,270,744 |
RGD:6480464 |
CTD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
affects expression |
ISO |
20 |
3,657,842 |
3,659,848 |
RGD:6480464 |
CTD |
| G |
Ltb4r2 |
leukotriene B4 receptor 2 |
|
decreases expression |
ISO |
15 |
33,923,472 |
33,924,548 |
RGD:6480464 |
CTD |
| G |
Mad1l1 |
MAD1 mitotic arrest deficient-like 1 (yeast) |
|
increases expression |
ISO |
12 |
14,793,899 |
15,107,476 |
RGD:6480464 |
CTD |
| G |
Magee1 |
melanoma antigen, family E, 1 |
|
decreases expression |
ISO |
X |
93,192,218 |
93,195,765 |
RGD:6480464 |
CTD |
| G |
Man2a1 |
mannosidase, alpha, class 2A, member 1 |
|
decreases expression |
ISO |
9 |
103,302,748 |
103,521,769 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
multiple interactions |
EXP |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
decreases activity |
EXP |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Map3k1 |
mitogen activated protein kinase kinase kinase 1 |
|
increases expression |
EXP |
2 |
43,062,252 |
43,126,058 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mdfi |
MyoD family inhibitor |
|
decreases expression |
ISO |
9 |
8,623,038 |
8,641,388 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases phosphorylation |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases phosphorylation |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Meis1 |
Meis homeobox 1 |
|
decreases expression |
ISO |
14 |
99,693,567 |
99,832,273 |
RGD:6480464 |
CTD |
| G |
Meox2 |
mesenchyme homeobox 2 |
|
increases expression |
EXP |
6 |
55,895,760 |
55,957,066 |
RGD:6480464 |
CTD |
| G |
Mesp1 |
mesoderm posterior 1 homolog (mouse) |
|
decreases expression |
ISO |
1 |
135,571,777 |
135,573,295 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
multiple interactions |
EXP |
13 |
83,038,049 |
83,058,802 |
RGD:6480464 |
CTD |
| G |
Mmp11 |
matrix metallopeptidase 11 |
|
decreases expression |
ISO |
20 |
13,129,667 |
13,138,449 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
increases expression |
ISO |
8 |
4,526,018 |
4,533,730 |
RGD:6480464 |
CTD |
| G |
Ms4a6a |
membrane-spanning 4-domains, subfamily A, member 6A |
|
decreases expression |
ISO |
1 |
214,046,885 |
214,057,578 |
RGD:6480464 |
CTD |
| G |
Mvk |
mevalonate kinase |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
multiple interactions |
EXP |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
affects expression |
ISO |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Nfia |
nuclear factor I/A |
|
decreases expression |
EXP |
5 |
118,152,938 |
118,507,056 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases response to substance |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
affects response to substance |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nipal2 |
NIPA-like domain containing 2 |
|
increases expression |
EXP |
7 |
70,021,792 |
70,135,156 |
RGD:6480464 |
CTD |
| G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
increases expression |
ISO |
19 |
35,094,345 |
35,096,012 |
RGD:6480464 |
CTD |
| G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
increases expression |
ISO |
19 |
35,094,345 |
35,096,012 |
RGD:6480464 |
CTD |
| G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
|
multiple interactions |
ISO |
19 |
35,094,345 |
35,096,012 |
RGD:6480464 |
CTD |
| G |
Notch1 |
notch 1 |
|
increases expression |
EXP |
3 |
4,631,797 |
4,677,640 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases activity |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
increases expression |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases activity |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases expression |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
increases expression |
ISO |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
increases activity |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
multiple interactions |
ISO |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
decreases expression |
ISO |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Ntf3 |
neurotrophin 3 |
|
multiple interactions |
EXP |
4 |
162,435,781 |
162,506,961 |
RGD:6480464 |
CTD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
decreases expression |
EXP |
2 |
179,838,740 |
179,855,545 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
decreases expression |
ISO |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
decreases expression |
EXP |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
multiple interactions |
ISO |
2 |
31,317,090 |
31,367,485 |
RGD:6480464 |
CTD |
| G |
Olr1366 |
olfactory receptor 1366 |
|
decreases expression |
EXP |
10 |
12,334,211 |
12,335,155 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
increases activity |
ISO |
13 |
96,309,670 |
96,341,486 |
RGD:6480464 |
CTD |
| G |
Pdk1 |
pyruvate dehydrogenase kinase, isozyme 1 |
|
multiple interactions |
ISO |
3 |
54,292,076 |
54,319,242 |
RGD:6480464 |
CTD |
| G |
Pdp2 |
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
|
multiple interactions |
EXP |
19 |
307,961 |
312,004 |
RGD:6480464 |
CTD |
| G |
Pkib |
protein kinase (cAMP-dependent, catalytic) inhibitor beta |
|
decreases expression |
ISO |
20 |
36,655,506 |
36,750,474 |
RGD:6480464 |
CTD |
| G |
Pla2g12a |
phospholipase A2, group XIIA |
|
increases expression |
ISO |
2 |
227,331,049 |
227,348,091 |
RGD:6480464 |
CTD |
| G |
Pla2g6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
|
multiple interactions |
ISO |
7 |
117,266,784 |
117,307,172 |
RGD:6480464 |
CTD |
| G |
Pla2g6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
|
increases expression |
ISO |
7 |
117,266,784 |
117,307,172 |
RGD:6480464 |
CTD |
| G |
Pld1 |
phospholipase D1 |
|
increases activity |
EXP |
2 |
115,306,940 |
115,460,518 |
RGD:6480464 |
CTD |
| G |
Plin2 |
perilipin 2 |
|
multiple interactions |
EXP |
5 |
105,718,496 |
105,732,817 |
RGD:6480464 |
CTD |
| G |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
|
multiple interactions |
EXP |
18 |
35,865,837 |
36,318,308 |
RGD:6480464 |
CTD |
| G |
Prap1 |
proline-rich acidic protein 1 |
|
increases expression |
ISO |
1 |
199,889,629 |
199,893,425 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
increases expression |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
increases activity |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prss8 |
protease, serine, 8 |
|
increases expression |
EXP |
1 |
187,210,556 |
187,215,072 |
RGD:6480464 |
CTD |
| G |
Psat1 |
phosphoserine aminotransferase 1 |
|
increases expression |
EXP |
1 |
219,268,419 |
219,290,273 |
RGD:6480464 |
CTD |
| G |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
|
increases expression |
ISO |
16 |
23,194,137 |
23,662,010 |
RGD:6480464 |
CTD |
| G |
Ptger1 |
prostaglandin E receptor 1 (subtype EP1) |
|
increases expression |
ISO |
19 |
26,160,729 |
26,163,156 |
RGD:6480464 |
CTD |
| G |
Ptprd |
protein tyrosine phosphatase, receptor type, D |
|
increases expression |
EXP |
5 |
94,069,724 |
94,286,657 |
RGD:6480464 |
CTD |
| G |
Qsox1 |
quiescin Q6 sulfhydryl oxidase 1 |
|
affects expression |
ISO |
13 |
70,739,793 |
70,777,526 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
increases phosphorylation |
ISO |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
|
multiple interactions |
ISO |
4 |
151,752,583 |
151,775,609 |
RGD:6480464 |
CTD |
| G |
Rasl10b |
RAS-like, family 10, member B |
|
decreases expression |
ISO |
10 |
71,492,903 |
71,503,357 |
RGD:6480464 |
CTD |
| G |
Rcbtb1 |
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1 |
|
affects expression |
ISO |
15 |
38,291,075 |
38,371,308 |
RGD:6480464 |
CTD |
| G |
RGD1305254 |
similar to transmembrane protein 2 |
|
increases expression |
ISO |
1 |
140,202,914 |
140,360,061 |
RGD:6480464 |
CTD |
| G |
Rho |
rhodopsin |
|
increases expression |
ISO |
4 |
152,057,788 |
152,062,950 |
RGD:6480464 |
CTD |
| G |
Rhob |
ras homolog family member B |
|
affects expression |
ISO |
6 |
32,052,333 |
32,054,507 |
RGD:6480464 |
CTD |
| G |
Rnf207 |
ring finger protein 207 |
|
decreases expression |
ISO |
5 |
169,537,947 |
169,550,915 |
RGD:6480464 |
CTD |
| G |
Rpgrip1 |
retinitis pigmentosa GTPase regulator interacting protein 1 |
|
decreases expression |
ISO |
15 |
27,574,762 |
27,582,641 |
RGD:6480464 |
CTD |
| G |
Rprd1b |
regulation of nuclear pre-mRNA domain containing 1B |
|
decreases expression |
ISO |
3 |
148,736,594 |
148,783,743 |
RGD:6480464 |
CTD |
| G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
|
increases expression |
ISO |
6 |
44,100,775 |
44,113,910 |
RGD:6480464 |
CTD |
| G |
RT1-Ba |
RT1 class II, locus Ba |
|
affects expression |
ISO |
20 |
4,697,971 |
4,702,564 |
RGD:6480464 |
CTD |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
increases expression |
EXP |
20 |
4,730,559 |
4,736,201 |
RGD:6480464 |
CTD |
| G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
multiple interactions |
ISO |
20 |
4,671,489 |
4,681,058 |
RGD:6480464 |
CTD |
| G |
RT1-DMa |
RT1 class II, locus DMa |
|
multiple interactions |
ISO |
20 |
4,843,458 |
4,846,861 |
RGD:6480464 |
CTD |
| G |
RT1-DMb |
RT1 class II, locus DMb |
|
multiple interactions |
ISO |
20 |
4,829,535 |
4,836,772 |
RGD:6480464 |
CTD |
| G |
Samd9l |
sterile alpha motif domain containing 9-like |
|
affects expression |
ISO |
4 |
28,180,523 |
28,185,536 |
RGD:6480464 |
CTD |
| G |
Scamp5 |
secretory carrier membrane protein 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
multiple interactions |
ISO |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scd |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
increases expression |
EXP |
1 |
249,358,105 |
249,371,164 |
RGD:6480464 |
CTD |
| G |
Scg5 |
secretogranin V (7B2 protein) |
|
increases expression |
ISO |
3 |
99,629,194 |
99,674,523 |
RGD:6480464 |
CTD |
| G |
Sema6a |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
|
decreases expression |
ISO |
18 |
41,545,350 |
41,665,721 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
decreases expression |
ISO |
2 |
52,451,883 |
52,462,263 |
RGD:6480464 |
CTD |
| G |
Serpina7 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
|
multiple interactions |
EXP |
X |
126,739,203 |
126,744,763 |
RGD:6480464 |
CTD |
| G |
Serpinb6 |
serpin peptidase inhibitor, clade B (ovalbumin), member 6 |
|
multiple interactions |
ISO |
17 |
37,316,389 |
37,335,124 |
RGD:6480464 |
CTD |
| G |
Sgol1 |
shugoshin-like 1 (S. pombe) |
|
increases expression |
ISO |
9 |
863,665 |
876,405 |
RGD:6480464 |
CTD |
| G |
Six4 |
SIX homeobox 4 |
|
affects expression |
ISO |
6 |
95,526,293 |
95,539,953 |
RGD:6480464 |
CTD |
| G |
Slc13a3 |
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 |
|
multiple interactions |
EXP |
3 |
156,447,900 |
156,510,620 |
RGD:6480464 |
CTD |
| G |
Slc16a6 |
solute carrier family 16, member 6 (monocarboxylic acid transporter 7) |
|
affects expression |
ISO |
10 |
98,853,289 |
98,875,189 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
increases expression |
ISO |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc1a4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
|
decreases expression |
ISO |
14 |
101,123,740 |
101,153,790 |
RGD:6480464 |
CTD |
| G |
Slc23a1 |
solute carrier family 23 (nucleobase transporters), member 1 |
|
increases expression |
ISO |
18 |
28,238,953 |
28,250,889 |
RGD:6480464 |
CTD |
| G |
Slc51b |
solute carrier family 51, beta subunit |
|
affects expression |
ISO |
8 |
69,661,815 |
69,669,889 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
increases expression |
ISO |
10 |
67,134,790 |
67,155,891 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
multiple interactions |
EXP |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Slc8a3 |
solute carrier family 8 (sodium/calcium exchanger), member 3 |
|
increases expression |
ISO |
6 |
105,012,888 |
105,159,942 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral membrane |
|
increases expression |
ISO |
19 |
36,112,166 |
36,195,564 |
RGD:6480464 |
CTD |
| G |
Snrk |
SNF related kinase |
|
decreases expression |
EXP |
8 |
121,958,351 |
121,968,989 |
RGD:6480464 |
CTD |
| G |
Snx16 |
sorting nexin 16 |
|
decreases expression |
ISO |
2 |
93,274,839 |
93,296,194 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
increases phosphorylation |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
multiple interactions |
EXP |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
Srd5a1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
|
multiple interactions |
EXP |
17 |
3,845,190 |
3,879,165 |
RGD:6480464 |
CTD |
| G |
Srd5a2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
|
multiple interactions |
EXP |
6 |
21,453,521 |
21,489,408 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
decreases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
decreases expression |
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:6480464 |
CTD |
| G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
|
multiple interactions |
ISO |
7 |
120,522,511 |
120,580,212 |
RGD:6480464 |
CTD |
| G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
|
decreases expression |
ISO |
7 |
120,522,511 |
120,580,212 |
RGD:6480464 |
CTD |
| G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
|
decreases expression |
ISO |
7 |
120,522,511 |
120,580,212 |
RGD:6480464 |
CTD |
| G |
Srf |
serum response factor (c-fos serum response element-binding transcription factor) |
|
increases expression |
ISO |
9 |
9,788,378 |
9,797,639 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
multiple interactions |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
increases expression |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Ssr3 |
signal sequence receptor, gamma |
|
decreases expression |
EXP |
2 |
155,147,350 |
155,156,029 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
multiple interactions |
EXP |
11 |
79,125,031 |
79,126,216 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
EXP |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
decreases expression |
EXP |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
increases expression |
EXP |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Sult2a1 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
|
decreases expression |
EXP |
1 |
75,632,632 |
75,708,022 |
RGD:6480464 |
CTD |
| G |
Sympk |
symplekin |
|
decreases expression |
ISO |
1 |
78,377,890 |
78,407,581 |
RGD:6480464 |
CTD |
| G |
Tcea2 |
transcription elongation factor A (SII), 2 |
|
affects expression |
ISO |
3 |
170,831,286 |
170,839,091 |
RGD:6480464 |
CTD |
| G |
Tcf15 |
transcription factor 15 |
|
increases expression |
ISO |
3 |
142,491,664 |
142,497,446 |
RGD:6480464 |
CTD |
| G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
increases expression |
ISO |
4 |
28,807,080 |
28,811,502 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
multiple interactions |
EXP |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
multiple interactions |
ISO |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
increases expression |
ISO |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
decreases expression |
ISO |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
multiple interactions |
ISO |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
increases expression |
ISO |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
multiple interactions |
ISO |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tjp1 |
tight junction protein 1 |
|
decreases expression |
EXP |
1 |
119,684,774 |
119,750,532 |
RGD:6480464 |
CTD |
| G |
Tktl1 |
transketolase-like 1 |
|
increases expression |
ISO |
X |
160,144,916 |
160,177,852 |
RGD:6480464 |
CTD |
| G |
Tlr6 |
toll-like receptor 6 |
|
decreases expression |
ISO |
14 |
46,089,365 |
46,100,687 |
RGD:6480464 |
CTD |
| G |
Tm4sf19 |
transmembrane 4 L six family member 19 |
|
increases expression |
ISO |
11 |
70,189,725 |
70,201,499 |
RGD:6480464 |
CTD |
| G |
Tmem158 |
transmembrane protein 158 |
|
increases expression |
ISO |
8 |
128,037,014 |
128,038,012 |
RGD:6480464 |
CTD |
| G |
Tmem229a |
transmembrane protein 229A |
|
increases expression |
ISO |
4 |
51,417,197 |
51,422,216 |
RGD:6480464 |
CTD |
| G |
Tmem37 |
transmembrane protein 37 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfaip8l1 |
tumor necrosis factor, alpha-induced protein 8-like 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
increases expression |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
|
increases expression |
ISO |
15 |
40,051,695 |
40,117,968 |
RGD:6480464 |
CTD |
| G |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
|
multiple interactions |
ISO |
15 |
40,051,695 |
40,117,968 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
affects expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tns4 |
tensin 4 |
|
affects expression |
ISO |
10 |
87,849,160 |
87,868,697 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tram2 |
translocation associated membrane protein 2 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Trhr |
thyrotropin releasing hormone receptor |
|
decreases expression |
ISO |
7 |
80,050,671 |
80,095,991 |
RGD:6480464 |
CTD |
| G |
Trhr |
thyrotropin releasing hormone receptor |
|
multiple interactions |
ISO |
7 |
80,050,671 |
80,095,991 |
RGD:6480464 |
CTD |
| G |
Trhr |
thyrotropin releasing hormone receptor |
|
decreases expression |
EXP |
7 |
80,050,671 |
80,095,991 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
decreases expression |
ISO |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
decreases expression |
EXP |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Ttc23 |
tetratricopeptide repeat domain 23 |
|
decreases expression |
ISO |
1 |
122,395,433 |
122,469,865 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
affects binding |
ISO |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
multiple interactions |
ISO |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
| G |
Tub |
tubby homolog (mouse) |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tubb3 |
tubulin, beta 3 class III |
|
increases expression |
ISO |
19 |
53,742,652 |
53,751,706 |
RGD:6480464 |
CTD |
| G |
Txnip |
thioredoxin interacting protein |
|
affects expression |
ISO |
2 |
191,356,954 |
191,360,757 |
RGD:6480464 |
CTD |
| G |
Tyk2 |
tyrosine kinase 2 |
|
increases phosphorylation |
ISO |
8 |
20,096,969 |
20,149,004 |
RGD:6480464 |
CTD |
| G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
|
increases expression |
EXP |
5 |
77,263,334 |
77,295,794 |
RGD:6480464 |
CTD |
| G |
Ugdh |
UDP-glucose 6-dehydrogenase |
|
increases expression |
ISO |
14 |
45,542,781 |
45,570,961 |
RGD:6480464 |
CTD |
| G |
Ugdh |
UDP-glucose 6-dehydrogenase |
|
increases expression |
ISO |
14 |
45,542,781 |
45,570,961 |
RGD:6480464 |
CTD |
| G |
Unc5b |
unc-5 homolog B (C. elegans) |
|
decreases expression |
ISO |
20 |
28,095,243 |
28,162,204 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
increases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
decreases expression |
ISO |
2 |
212,277,654 |
212,297,376 |
RGD:6480464 |
CTD |
| G |
Wnt3a |
wingless-type MMTV integration site family, member 3A |
|
multiple interactions |
EXP |
10 |
45,553,682 |
45,594,983 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
decreases expression |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Xiap |
X-linked inhibitor of apoptosis |
|
multiple interactions |
EXP |
X |
3,011,520 |
3,047,798 |
RGD:6480464 |
CTD |
| G |
Xrcc1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
multiple interactions |
ISO |
1 |
79,834,167 |
79,860,300 |
RGD:6480464 |
CTD |
| G |
Xrcc3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
|
multiple interactions |
ISO |
6 |
136,594,276 |
136,602,069 |
RGD:6480464 |
CTD |
| G |
Zadh2 |
zinc binding alcohol dehydrogenase, domain containing 2 |
|
decreases expression |
ISO |
18 |
80,613,957 |
80,623,307 |
RGD:6480464 |
CTD |
| G |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
|
affects expression |
ISO |
6 |
103,119,555 |
103,124,576 |
RGD:6480464 |
CTD |
| G |
Zfp672 |
zinc finger protein 672 |
|
affects expression |
ISO |
10 |
43,953,238 |
43,961,467 |
RGD:6480464 |
CTD |
| G |
Zfp697 |
zinc finger protein 697 |
|
decreases expression |
ISO |
2 |
193,237,465 |
193,241,657 |
RGD:6480464 |
CTD |
Term paths to the root
| Path 1 |
CHEBI ontology |
492574 |
 |
chemical entity |
492574 |
 |
molecular entity |
475835 |
 |
polyatomic entity |
442085 |
 |
molecule |
364791 |
 |
cyclic compound |
300260 |
 |
ring assembly |
5114 |
 |
biaryl |
3229 |
 |
biphenyls |
3229 |
 |
chlorobiphenyl |
2152 |
 |
polychlorobiphenyl |
2145 |
 |
hexachlorobiphenyl |
421 |
 |
2,2',4,4',5,5'-hexachlorobiphenyl |
413 |
 |
| Path 2 |
CHEBI ontology |
492574 |
 |
subatomic particle |
491537 |
 |
composite particle |
491537 |
 |
hadron |
491537 |
 |
baryon |
491537 |
 |
nucleon |
491537 |
 |
atomic nucleus |
491537 |
 |
atom |
491537 |
 |
main group element atom |
461203 |
 |
main group molecular entity |
456122 |
 |
s-block molecular entity |
310368 |
 |
hydrogen molecular entity |
307614 |
 |
hydrides |
192538 |
 |
organic hydride |
118097 |
 |
organic fundamental parent |
118097 |
 |
| hydrocarbon |
70705 |
 |
halohydrocarbon |
10755 |
 |
haloarene |
3132 |
 |
chloroarene |
2559 |
 |
chlorobiphenyl |
2152 |
 |
polychlorobiphenyl |
2145 |
 |
hexachlorobiphenyl |
421 |
 |
2,2',4,4',5,5'-hexachlorobiphenyl |
413 |
 |
| |
|